Prostate | Qritive

NEWS & EVENTS

SEE WHAT’S NEW AT QRITIVE—FROM BREAKTHROUGH STUDIES TO STRATEGIC COLLABORATIONS AND EVENT SHOWCASES.

Stay up to date with Qritive’s latest news, events, and announcements as we advance the future of digital pathology through global collaboration, scientific innovation, and clinical milestones.

QAi Prostate Grade Receives Class C IVD Approval from Singapore’s Health Sciences Authority

Qritive is proud to announce that its AI-powered diagnostic solution, QAi Prostate Grade, has received Class C In Vitro Diagnostic (IVD) registration from Singapore’s Health Sciences Authority (HSA). This approval marks a major milestone in expanding the clinical use of artificial intelligence in prostate cancer diagnostics.

News

Aug 5

QAi Prostate Grade Receives Regulatory Approval from Abu Dhabi’s Department of Health

Qritive is pleased to announce that its AI-powered solution, QAi Prostate Grade, has received official market approval from the Department of Health – Abu Dhabi following a comprehensive Health Technology Assessment (HTA). This approval marks a major milestone in expanding the clinical use of artificial intelligence in prostate cancer diagnostics.

News

Jul 28